Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CytomX Therapeutics (CTMX) Interest & Investment Income: 2013-2024

Historic Interest & Investment Income for CytomX Therapeutics (CTMX) over the last 12 years, with Dec 2024 value amounting to $7.1 million.

  • CytomX Therapeutics' Interest & Investment Income fell 5.97% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year decrease of 40.16%. This contributed to the annual value of $7.1 million for FY2024, which is 27.46% down from last year.
  • Per CytomX Therapeutics' latest filing, its Interest & Investment Income stood at $7.1 million for FY2024, which was down 27.46% from $9.8 million recorded in FY2023.
  • CytomX Therapeutics' Interest & Investment Income's 5-year high stood at $9.8 million during FY2023, with a 5-year trough of $255,000 in FY2021.
  • Over the past 3 years, CytomX Therapeutics' median Interest & Investment Income value was $7.1 million (recorded in 2024), while the average stood at $6.2 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first crashed by 86.11% in 2021, then spiked by 558.04% in 2022.
  • Over the past 5 years, CytomX Therapeutics' Interest & Investment Income (Yearly) stood at $1.8 million in 2020, then tumbled by 86.11% to $255,000 in 2021, then soared by 558.04% to $1.7 million in 2022, then spiked by 486.23% to $9.8 million in 2023, then declined by 27.46% to $7.1 million in 2024.